AbbVie Inc. - Common Stock (ABBV) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
ABBV on NYSE
Shares outstanding
1,767,364,935
Price per share
$218.67
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
1,310,421,085
Total reported value
$299,181,133,098
% of total 13F portfolios
0.24%
Share change
+40,268,486
Value change
+$9,177,210,659
Number of holders
4,020
Price from insider filings
$218.67
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of AbbVie Inc. - Common Stock (ABBV) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 10% $32,904,227,684 177,266,703 The Vanguard Group 30 Jun 2025

As of 31 Dec 2025, 4,020 institutional investors reported holding 1,310,421,085 shares of AbbVie Inc. - Common Stock (ABBV). This represents 74% of the company’s total 1,767,364,935 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of AbbVie Inc. - Common Stock (ABBV) together control 48% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 10% 180,779,699 +1.7% 0.6% $41,306,353,424
BlackRock, Inc. 8.6% 151,174,543 +3.6% 0.59% $34,541,871,411
STATE STREET CORP 4.6% 80,940,931 +1.4% 0.62% $18,494,193,324
JPMORGAN CHASE & CO 3% 52,393,323 -7.3% 0.81% $11,971,351,030
GEODE CAPITAL MANAGEMENT, LLC 2.5% 44,629,980 +10% 0.63% $10,179,098,610
MORGAN STANLEY 2.3% 40,041,940 -3.9% 0.55% $9,149,183,466
BANK OF AMERICA CORP /DE/ 1.5% 25,824,399 +2.7% 0.43% $5,900,616,785
NORGES BANK 1.5% 25,668,761 0.63% $5,865,055,201
Capital Research Global Investors 1.4% 25,408,200 +0.7% 1.1% $5,805,529,521
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.4% 25,169,844 -3% 0.89% $5,751,060,095
FMR LLC 1.3% 22,609,389 +7.5% 0.26% $5,166,019,290
NORTHERN TRUST CORP 1.2% 21,733,923 -1.4% 0.63% $4,965,984,066
WELLINGTON MANAGEMENT GROUP LLP 0.84% 14,926,683 +42% 0.6% $3,410,597,797
FRANKLIN RESOURCES INC 0.84% 14,881,504 +2.3% 0.83% $3,400,274,102
Bank of New York Mellon Corp 0.76% 13,499,351 +9.7% 0.54% $3,084,466,589
Capital World Investors 0.74% 13,071,444 +106% 0.41% $2,986,777,322
GOLDMAN SACHS GROUP INC 0.73% 12,980,560 -3.1% 0.42% $2,965,928,157
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.73% 12,924,311 +2.7% 0.62% $2,953,075,820
Legal & General Group Plc 0.69% 12,133,331 +1.1% 0.61% $2,772,344,798
Capital International Investors 0.66% 11,692,765 +9.2% 0.42% $2,671,982,867
UBS Group AG 0.6% 10,526,920 -10% 0.48% $2,405,295,950
Amundi 0.59% 10,450,406 -0.55% 0.74% $2,387,813,268
DEUTSCHE BANK AG\ 0.57% 10,129,714 +7.1% 0.75% $2,314,538,352
AMERIPRISE FINANCIAL INC 0.57% 10,060,638 +4% 0.52% $2,298,902,337
PRICE T ROWE ASSOCIATES INC /MD/ 0.56% 9,826,388 -7.3% 0.24% $2,245,232,000

Institutional Holders of AbbVie Inc. - Common Stock (ABBV) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,310,421,085 $299,181,133,098 +$9,177,210,659 $228.49 4,020
2025 Q3 1,269,893,423 $293,767,209,154 -$3,124,011,828 $231.54 3,873
2025 Q2 1,287,075,518 $238,891,433,790 +$4,866,082,603 $185.62 3,742
2025 Q1 1,261,493,107 $264,023,235,689 -$2,130,141,483 $209.52 3,780
2024 Q4 1,275,092,654 $226,558,537,921 +$1,209,556,751 $177.70 3,709
2024 Q3 1,263,246,128 $249,268,364,641 +$88,413,171 $197.48 3,466
2024 Q2 1,262,725,926 $216,474,972,193 +$1,915,850,329 $171.52 3,339
2024 Q1 1,253,088,393 $227,875,219,935 +$2,788,759,396 $182.10 3,353
2023 Q4 1,239,748,668 $192,192,568,041 +$1,517,401,072 $154.97 3,297
2023 Q3 1,228,903,942 $183,197,476,249 +$1,009,113,820 $149.06 3,092
2023 Q2 1,221,315,614 $164,787,374,519 -$1,664,070,544 $134.73 3,053
2023 Q1 1,233,425,991 $196,519,460,228 +$259,081,467 $159.37 3,117
2022 Q4 1,235,502,434 $199,621,628,438 +$2,752,393,686 $161.61 3,144
2022 Q3 1,221,220,466 $164,097,646,774 +$170,284,213 $134.21 2,949
2022 Q2 1,217,745,031 $186,477,353,594 +$3,489,007,770 $153.16 2,980
2022 Q1 1,203,308,144 $195,040,563,504 +$2,450,810,000 $162.11 3,033
2021 Q4 1,188,323,728 $160,862,723,207 +$1,040,998,406 $135.40 2,954
2021 Q3 1,177,170,536 $127,005,644,713 -$384,320,770 $107.87 2,641
2021 Q2 1,182,050,895 $133,115,260,852 -$647,210,591 $112.64 2,657
2021 Q1 1,186,224,948 $128,344,178,557 -$1,087,268,478 $108.22 2,595
2020 Q4 1,197,885,694 $128,301,295,744 -$1,070,454,735 $107.15 2,580
2020 Q3 1,210,244,308 $105,941,681,033 -$1,507,877,911 $87.59 2,356
2020 Q2 1,226,149,387 $120,286,919,217 +$14,394,795,664 $98.18 2,397
2020 Q1 1,079,313,793 $82,241,542,825 +$791,234,318 $76.19 2,213
2019 Q4 1,067,427,836 $94,486,529,954 +$1,223,798,676 $88.54 2,231
2019 Q3 1,056,424,195 $79,981,092,369 +$2,749,727,052 $75.72 1,995
2019 Q2 1,020,107,599 $74,140,080,434 +$134,418,416 $72.72 2,013
2019 Q1 1,025,594,398 $82,642,729,287 -$1,357,273,013 $80.59 2,023
2018 Q4 1,043,063,858 $96,057,755,521 -$2,268,195,432 $92.19 2,054
2018 Q3 1,064,303,780 $100,606,565,412 -$228,478,920 $94.58 1,952
2018 Q2 1,066,935,394 $98,824,334,101 -$4,621,865,658 $92.65 1,988
2018 Q1 1,115,897,507 $105,577,975,508 -$635,075,420 $94.65 2,010
2017 Q4 1,124,483,239 $108,727,093,427 +$374,684,079 $96.71 1,990
2017 Q3 1,118,458,594 $99,379,513,075 +$1,309,956,795 $88.86 1,792
2017 Q2 1,104,509,124 $80,068,623,904 +$1,082,850,124 $72.51 1,761
2017 Q1 1,097,772,439 $71,530,343,434 +$6,012,078,996 $65.16 1,725
2016 Q4 1,094,423,119 $68,517,301,870 -$1,501,669,878 $62.62 1,686
2016 Q3 1,115,082,886 $70,272,962,866 -$935,916,366 $63.07 1,642
2016 Q2 1,128,170,500 $69,822,885,108 +$1,331,070,628 $61.91 1,624
2016 Q1 1,107,228,663 $63,240,024,329 -$234,331,465 $57.12 1,624
2015 Q4 1,114,783,288 $66,029,826,303 -$1,761,226,133 $59.24 1,627
2015 Q3 1,135,736,480 $61,795,060,747 -$3,097,342,097 $54.41 1,586
2015 Q2 1,197,000,259 $80,428,666,659 +$5,904,487,622 $67.19 1,642
2015 Q1 1,111,667,985 $65,099,745,699 -$591,285,996 $58.54 1,590
2014 Q4 1,121,324,839 $73,375,310,991 -$8,392,175,216 $65.44 1,596
2014 Q3 1,252,517,869 $72,342,438,122 +$8,158,820,153 $57.76 1,493
2014 Q2 1,110,338,015 $62,659,470,218 +$2,575,063,702 $56.44 1,448
2014 Q1 1,066,968,421 $54,829,249,328 +$103,303,847 $51.40 1,413